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Brink P, Wright JC, Schumacher J: An investigation of the ability of the glu-
taraldehyde test to distinguish between acute and chronic inflammatory disease in
horses. Acta vet. scand. 2005, 46, 69-78. – The glutaraldehyde test (GT), a rapid and
inexpensive test, has been utilized empirically for many years in bovine practice for di-
agnosing inflammatory diseases. GT is used primarily to demonstrate increased serum
concentrations of fibrinogen and globulin. Glutaraldehyde binds with free amino groups
in fibrinogen and immunoglobulin to create a clot in a first degree chemical reaction.
The clotting time of the GT estimates the content of proteins produced in response to in-
flammation. The applicability of GT for diagnosing inflammation in the horse has never
been investigated. The objective of this study was to determine the ability of GT to dis-
tinguish between acute and chronic inflammatory disease in horses. Thirty-seven horses
with suspected inflammatory diseases were evaluated using the GT, history, complete
clinical examination and routine blood analysis. GT-times, laboratory results and clini-
cal outcome were compared statistically. Horses that were determined to be acutely af-
fected (based on history, clinical examination and routine blood analysis) tended to have
a negative GT (75%). Results of the GT did not correlate with blood fibrinogen con-
centration. Positive GT also predicted a fatal outcome in 69% of the clinical cases. The
results of this trial indicate that GT can be a useful screening test to distinguish between
acute and chronic inflammatory disease in horses. 
Glutaraldehyde test, inflammation, horse diseases, equine, diagnostic techniques,
prognosis, immunoglobulin, globulin, blood clot, infectious diseases, hypergamma-
globulinemia, serum biochemistries.
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Introduction
The glutaraldehyde reagent in the glutaralde-
hyde test (GT) creates a clot with either fibrino-
gen or gammaglobulin in EDTA-stabilized
blood by chemical reaction between the alde-
hyde groups in glutaraldehyde and free amino
groups in fibrinogen and immunoglobulins
(Sandholm 1974a, Sandholm 1974b, Martin et
al. 1985). The process is believed to run as a
first degree chemical reaction, where the reac-
tion time is directly proportional to the concen-
tration of fibrinogen and immunoglobulins
(Sandholm 1974a, Sandholm 1974b, Eriksen
1984).
The rapid and inexpensive GT has been used
with success empirically in Europe for many
years for diagnosing inflammatory diseases in
cattle (Sandholm 1974a, Sandholm 1974b,
Liberg et al. 1975a, Liberg et al. 1975b, Nielsen
1975, Martens 1977, Liberg 1978, Tennant et
al. 1979, Liberg 1981, Liberg 1982, Eriksen
1984, Keulen et al. 1984, Doll et al. 1985, Lars-
son 1985, Mahlin et al. 1985, Chadli & Mahin
1986, Kovac 1988, Katholm & Jorgensen 1992,
Kantor et al. 1993, Tyler et al. 1996, Sen et al.
2000, Ramprabhu et al. 2002), pigs (Liberg
1979, Hansen 1985, Kovac et al. 1993), goats
(Satpathy et al. 1996, Vihan 1989), mink (Sand-
holm & Kangas 1973), dogs (Sandholm &
Kivisto 1975, Wolff 1986), and zoo animals
(O'-Rourke & Satterfield 1981, Carstairs-Grant
et al. 1988, Juyal & Uppal 1995). In these
species, the test was used to indicate whether an
inflammatory disease was acute or chronic
(Doll et al. 1985, Chadli & Mahin 1986). 
The GT, because of its simplicity, is very useful
in bovine practice for rapidly diagnosing in-
flammation under circumstances where it is not
practical or economically possible to have
blood analyzed at a professional clinical labora-
tory (Sandholm 1974a, Sandholm 1974b, Li-
berg et al. 1975a, Liberg et al. 1975b, Nielsen
1975, Martens 1977, Liberg 1978, Tennant et
al. 1979, Liberg 1981, Liberg 1982, Eriksen
1984, Keulen et al. 1984, Doll et al. 1985, Lars-
son 1985, Mahlin et al. 1985, Chadli & Mahin
1986, Kovac 1988, Katholm & Jorgensen 1992,
Kantor et al. 1993, Tyler et al. 1996, Sen et al.
2000, Ramprabhu et al. 2002).
A negative GT can be used as a semiquantita-
tive indicator of hypogammaglobulinemia
caused by failure of passive transfer of
colostrum in neonatal foals (Beetson et al.
1985, Clabough et al. 1989, Saikku et al. 1989,
Clabough et al. 1991, Kumaran & Bhuvanaku-
mar 1994, Kalinbacak & Or 1996, Bruijn et al.
2003), calves (Tennant et al. 1979, Keulen et al.
1984, Larsson 1985, Kovac 1988, Tyler et al.
1996, Sen et al. 2000), kids (Vihan 1989, Sat-
pathy et al. 1996), and zoo ruminants
(O'-Rourke & Satterfield 1981, Carstairs-
Grant et al. 1988, Juyal & Uppal 1995). The
GT also has been used to determine the content
of IgG in mare colostrum (Jones & Brook 1995,
Ezhilan & Bhuvanakumar 1998). 
Clinical experience indicates that the GT may
not be as reliable in horses as it is in cattle
(Nielsen 1975). In horses, lack of reliability of
the GT has been proposed to be caused by gen-
erally lower or delayed peaks of concentrations
of fibrinogen and immunoglobulin or a differ-
ent distribution of immunoglobulins (IgG, IgM,
IgA) compared to cattle (Bendixen 1954,
Nansen & Nielsen 1966, Sandholm 1974a,
Nielsen 1975, Aasted et al. 1989). 
The purpose of this clinical trial was to deter-
mine the ability of GT to distinguish between
acute and chronic inflammatory disease in
horses. During the trial we compared indicators
of inflammation (the concentration of blood fib-
rinogen and serum globulin) to the GT. 
Materials and methods 
Thirty seven horses admitted for investigation
of suspected inflammatory disease were evalu-
ated using the GT (Glutarvaca), a complete
clinical examination, CBC and routine serum
biochemistries that included total protein, albu-
min, globulin and fibrinogen. Blood for the GT
and laboratory analysis was collected at the
same time either upon arrival at the hospital or
the following day. 
Horses having a history of clinical signs of in-
flammatory disease of total duration six days or
less were arbitrarily classified as acutely in-
flamed. Horses with a history of clinical signs
greater than six days were arbitrarily classified
as chronically inflamed. The clinical examina-
tion leading to the diagnosis and etiology was
also used to reinforce the distinction between
acute and chronic disease (Table 1).
The GT was performed by adding equal
amounts of fresh blood and glutaraldehyde in a
test tube, mixing by slowly turning the test tube
and visually observing and noting the time re-
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Table 1: Diagnosis and outcome.
Horse # Diagnosis Duration Outcome
1 Purulent, bilateral guttural pouch empyema Chronic Fatal (spontaneous)
2 Dorsal rectal abscess Chronic Discharged
3 Traumatic, infected joint capsular laceration Acute Discharged
4 Dorsal rectal abscesses Chronic Discharged
5 Purulent nephritis, lung abscesses, ulcerous dermatitis, 
myocarditis, fatty liver Chronic Fatal (euthanasia)
6 Severe, idiopathic, systemic infection Acute Fatal (spontaneous)
7 Purulent (jugular) thrombophlebitis (abscess) Chronic Discharged
8 Transportation syndrome, bronchitis/pleuritis, 
systemic infection Acute Discharged
9 Fibrinopurulent pleuropneumonia Acute Fatal (euthanasia)
10 Systemic, malign lymphoma, borrelia infection Chronic Fatal (euthanasia)
11 Infected tendovaginitis Acute Discharged
12 Intraabdominal abscess, squamous cell carcinoma 
(ventricle) Chronic Fatal (euthanasia)
13 Septic, purulent arthritis Chronic Discharged
14 Fibrinopurulent pleuropneumonia Acute Fatal (euthanasia)
15 Septicemia, pneumonia, peritonitis Acute Fatal (euthanasia)
16 Severe, purulent, traumatic muscle laceration Chronic Discharged
17 Severe, iatrogenic, muscle abscesses Chronic Discharged
18 Purulent osteomyelitis Chronic Fatal (euthanasia)
19 Severe subcutaneous infection/abscess, funiculitis Chronic Discharged
20 Humerus fracture, subcutaneous infection/abscess Chronic Discharged
21 Bacterial diarrhea Acute Fatal (euthanasia)
22 Abscess, inguinal region Chronic Discharged
23 Scrotal abscesses, postoperative castration Chronic Discharged
24 Necrotizing myositis, multiple subcutaneous abscesses Chronic Discharged
25 Fibrinopurulent septic bicipital bursitis, muscular 
septic cellulitis Chronic Fatal (euthanasia)
26 Pericarditis, mitral insufficiency, systemic infection Chronic Fatal (euthanasia)
27 Septic peritonitis Chronic Discharged
28 Septic meningitis Acute Discharged
29 Septicemia, premature foal Acute Discharged
30 M. Masseter, throat latch, parotid, jugular 
abscesses/fistulae Chronic Discharged
31 Systemic infection, septic myositis Chronic Fatal (euthanasia)
32 Systemic infection, possible abdominal/kidney abscess, 
emaciation Chronic Fatal (euthanasia)
33 Severe, multiple, purulent, septic arthritis Chronic Fatal (euthanasia)
34 Metritis, purulent peritonitis, abdominal abscesses, 
adherences Chronic Fatal (euthanasia)
35 Purulent, pharyngeal inflammation, choke Acute Discharged
36 Thrombosis pulmonary vessels, Cushing disease,
laminitis Chronic Fatal (euthanasia)
37 Systemic intoxication, parasitic aneurysm, intestinal 
volvulus, paralysis Acute Fatal (euthanasia)
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Table 2: Categorization of GT-time.
Group # GT-times Empiric categorization
1 0 < GT-time < 3 min. High increase in concentration of fibrinogen and/or immunoglobulin
2 3 < GT-time < 6 min. Moderate increase in concentration of fibrinogen and/or immunoglobulin
3 6 < GT-time < 15 min. Low increase in concentration of fibrinogen and/or immunoglobulin
4 GT >15 min. No increase in concentration of fibrinogen and/or immunoglobulin
Table 3: Blood values
Horse GT- Al- Glo- Alb/ Fibri- Total WBC
Differential cell count leukocytes
Hemo-
# time bumin bulin Glob nogen prot. (10.9/l) Bands Segm Eosin Mono Lymph Baso RBC globin PCV
(min) (g/l) (g/l) (ratio) (g/l) (g/l) (%) (%) (%) (%) (%) (%) (10.12/l) (g/l) (%)
1 2,0 30 58 0,5 7,1 88 9,4 1 63 0 4 32 0 8,8 113 31
2 NR 30 35 0,9 7,5 65 9,3 0 42 0 5 53 0 9,7 118 33
3 NR 38 30 1,3 3,6 68 9,4 0 67 1 1 31 0 8,5 123 34
4 NR 27 35 0,8 4,7 62 7,0 3 24 2 3 66 2 8,2 110 30
5 NR 41 33 1,2 2,3 74 16,7 0 85 0 5 9 1 11,6 178 48
6 3,5 31 40 0,8 8,3 71 10,2 2 79 0 4 15 0 7,3 117 33
7 NR 36 37 1,0 7,7 73 16,0 5 78 0 1 16 0 11,7 186 50
8 NR 34 42 0,8 4,4 76 9,3 2 68 1 3 25 1 7,3 125 35
9 NR 32 37 0,9 9,9 69 9,2 11 64 0 4 21 0 8,6 144 39
10 1,0 17 63 0,3 3,0 80 15,8 0 80 1 4 14 1 1,1 27 8
11 NR 31 48 0,6 8,2 79 6,2 0 61 1 4 34 0 5,9 102 28
12 6,0 32 60 0,5 5,2 92 7,0 0 74 1 5 20 0 7,0 130 34
13 NR 34 29 1,2 5,9 63 11,1 0 68 0 3 29 0 8,0 105 31
14 5,0 18 47 0,4 7,1 65 10,3 3 59 0 8 30 0 9,2 153 45
15 NR 23 27 0,9 6,4 50 2,8 7 11 0 5 77 0 12,8 176 50
16 NR 33 25 1,3 2,9 58 7,4 1 68 6 1 23 1 7,8 136 38
17 NR 31 29 1,1 5,4 60 7,3 0 56 2 6 36 0 10,1 168 48
18 NR 27 25 1,1 4,9 52 35,4 0 94 0 3 3 0 6,5 137 39
19 3,0 29 58 0,5 6,8 87 19,2 1 72 2 1 24 0 5,8 85 26
20 NR 33 20 1,7 12,2 53 15,0 0 75 0 6 19 0 9,1 121 35
21 NR 20 18 1,1 7,0 38 36,6 0 90 0 1 9 0 10,3 136 37
22 3,0 21 69 0,3 5,0 90 30,7 0 85 1 1 13 0 6,3 92 24
23 NR 21 36 0,6 6,0 57 7,5 0 54 2 2 41 1 6,3 107 28
24 NR 21 19 1,1 5,0 40 13,7 1 87 0 2 10 0 5,5 72 19
25 NR 36 31 1,2 6,6 67 8,6 0 77 0 8 14 0 5,6 101 27
26 NR 35 22 1,6 6,0 57 10,8 0 86 2 2 10 0 8,3 141 41
27 5,0 31 46 0,7 9,0 77 13,5 0 72 0 3 25 0 7,4 119 32
28 NR 25 41 0,6 10,0 66 33,4 0 93 0 6 1 0 10,5 126 32
29 NR 32 16 2,0 5,0 48 0,8 0 16 0 0 84 0 7,7 117 31
30 NR 28 21 1,3 14,7 49 26,4 0 72 0 9 18 1 8,1 98 25
31 15,0 40 27 1,5 7,3 67 11,5 1 78 1 2 17 1 6,8 118 31
32 NR 36 19 1,9 4,6 55 15,0 2 42 2 7 47 0 9,3 116 32
33 15,0 29 44 0,7 4,8 73 8,0 1 45 0 9 45 0 8,0 128 35
34 14,0 21 23 0,9 5,8 44 9,4 0 90 2 2 6 0 6,2 114 31
35 2,0 31 42 0,7 11,0 73 12,0 0 75 1 2 21 1 5,1 83 20
36 3,0 32 41 0,8 5,0 73 16,7 0 93 0 2 5 0 4,3 80 20
37 NR 33 39 0,8 6,3 72 11,9 0 76 0 7 17 0 11,7 185 53
* NR = no reaction
quired for full clot formation. The test result
was categorized respectively as high, moderate,
low or no increase in concentration of fibrino-
gen and/or immunoglobulin based on GT-time
(Table 2).
The results of the GT and fibrinogen, globulin
and albumin/globulin ratio were compared us-
ing regression and correlation. The association
of the GT results with fatality was analyzed us-
ing chi-square. All data from the blood analysis
were also tested for correlation with GT using
principal component analysis.
Results
In Table 1, diagnoses, estimated duration of the
diseases and outcome of the clinical cases are
summarized. 
In Table 3, the GT-times and results of blood
analysis of the horses are summarized. 
Table 4 shows the mean concentration of se-
lected blood values for horses whose blood had
positive reaction to the GT, compared to horses
whose blood had a negative reaction to the GT.
Table 5 shows the comparison of selected clini-
cal parameters and mean blood values of horses
with positive GT.
The GT-times were divided into groups as listed
in Table 6. Table 7 shows the correlation of GT-
time and Group number versus globulin con-
centration and albumin/globulin ratio, respec-
tively, by linear regression. The regression
equations are also shown in Graphs 1-4. Group
number did not correlate with the mean fibrino-
gen concentration within groups. 
Among the hospitalized horses, there was a
higher fatality rate in the GT positive horses
(69% = 9/13) when compared to the GT nega-
tive horses (38% = 9/24); however, this finding
was not statistically significant (p=0.06, Chi
square test).
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Table 4: GT result versus mean blood values (+/- standard deviation).
Albumin (g/l) Globulin (g/l) Alb/Glo (ratio) Fibrinogen (g/l)
GT-positive 27,9 (+/- 6,6) 47,5 (+/- 13,7) 0,7 (+/- 0,3) 6,6 (+/- 2,1)
GT-negative 30,7 (+/- 5,7) 29,3 (+/- 8,7) 1,1 (+/- 0,4) 6,6 (+/- 2,9)
All horses 29,7 (+/- 6,1) 36,0 (+/- 13,6) 1,0 (+/- 0,4) 6,6 (+/- 2,6)
Table 5: Clinical parameters versus mean blood values.
GT-positive (%) Albumin (g/l) Globulin (g/l) Alb/Glo (ratio) Fibrinogen (g/l)
Duration Acute 23,1 26,7 43,0 0,6 8,8
Chronic 76,9 28,2 48,9 0,7 5,9
Outcome Fatal 69,2 27,8 44,8 0,7 6,0
Discharged 30,8 28,0 53,8 0,6 8,0
Table 6: GT-time groups versus mean blood values within groups (+/- standard deviation).
Group # GT-positive (No) Mean Globulin (g/l) Mean Alb/Glo (ratio) Mean Fibrinogen (g/l)
1: (0<GT-time<3 min.) 6 55,2 (+/- 11,3) 0,5 (+/- 0,2) 6,3 (+/- 2,7)
2: (3<GT-time<6 min.) 4 48,3 (+/- 8,4) 0,6 (+/- 0,2) 7,4 (+/- 1,7)
3: (6<GT-time<15 min.) 3 31,3 (+/- 11,2) 1,0 (+/- 0,4) 6,0 (+/- 2,0)
4: (GT-time>15 min.) 24 29,3 (+/- 8,7) 1,1 (+/- 0,4) 6,6 (+/- 2,9)
Among the 37 horses, the proportion of test
negatives of horses that were acutely inflamed
was 75% (9/12). The proportion of acutely in-
flamed test negatives was significantly greater
than the proportion of chronically inflamed test
positives (p=0.04, Chi square test). The propor-
tion of test positives of horses that were chron-
ically inflamed was 40% (10/25).
The GT did not show statistically significant
correlation with the concentration of blood fib-
rinogen in acute or chronic diseases.
All results from the blood analyses (Table 3)
were also compared to the GT using principal
component analysis without finding any statis-
tically significant correlation.
Discussion
The results of this study indicate that the GT
can be used to quickly differentiate chronic
from acute inflammatory disease in horses. The
high proportion of test negatives of horses hav-
ing acute inflammation indicates that horses
with inflammatory disease and negative GT are
likely to be acutely, rather than chronically, in-
flamed. Among GT positive horses, 77% were
chronically inflamed as shown in Table 5. The
GT was not reliable in predicting the blood con-
centration of fibrinogen in acute or chronic in-
flammatory diseases.
Useful clinical information could be obtained
by dividing GT-times into categories (groups)
as listed in Table 2 (Liberg et al. 1975a, Liberg
et al. 1975b). Comparison of category and re-
spectively globulin concentration and albu-
min/globulin ratio within a category seemed to
correlate, although this tendency was not statis-
tically significant. This could be due to the
small number of data points. A larger number
of horses included in a future study like ours
would probably eliminate this statistical uncer-
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Table 7: GT-time and Group# correlation with globulin concentration and albumin/globulin. Linear regression
and regression coefficient.
Dependent variable Independent variable (equation) r
GT-time - 0,22 [globulin] + 16,33 0,61
GT-time 10,84 [albumin/globulin] - 1,21 0,67
Group # - 0,10 [mean globulin within groups] + 6,50 0,96




tainty. The correlation above has been observed
in cattle (Sandholm 1974a, Liberg et al. 1975a,
Liberg et al. 1975b, Nielsen 1975, Eriksen
1984). The difference between other studies of
other species and this study was that horses in
Group 1 had only moderately increased globu-
lin concentration and moderately decreased al-
bumin/globulin ratio, Group 2 horses had a
mildly increased globulin concentration and
mildly decreased albumin/globulin ratio, and
horses in Group 3 had a globulin concentration
and albumin/globulin ratio within normal
range. 
If the clinical examination indicates systemic
infection (eg. increased rectal temperature) and
the GT is positive, the probability is high (77%
likelihood) for chronic inflammatory disease. A
positive GT acts then as an indicator for further
laboratory analysis of blood to determine
chronicity and etiology of the disease. If the test
is negative, the disease is most likely acute or
the systemic inflammatory response is either
insignificant or absent. The GT can also be
used as an additional diagnostic test to indicate
prognosis because a positive test predicted fatal
outcome in 69% of the clinical cases we stud-
ied. The test performance regarding the pre-
dictability of a fatal outcome might increase if
only severe inflammatory diseases are included
as compared to a study also including mild
cases (selection bias). Also, the lack of controls
will add bias to the percentages and will elimi-
nate false positives. Because the study did not
include a group of controls and a group of
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Graph 3. Regression of GT time Group vs Mean
Globulin.




horses suffering from non-inflammatory dis-
eases, the data presented can only be consid-
ered valid for horses with inflammatory dis-
ease. For this reason, the conclusions are not
valid for the entire population of horses. The se-
lection of horses among patients submitted to a
large referral hospital also might introduce
spectrum bias as the hospitalized horses are
more likely to be severely affected than horses
treated in practice.
A positive GT in horses indicated the probabil-
ity of increased serum concentration of globu-
lin and a decreased albumin/globulin ratio, but
the GT was not correlated with the blood con-
centration of fibrinogen. 
Taking into consideration the low cost and rapid
application of the GT and correlation of a posi-
tive test with increased concentration of globu-
lin, the GT is a useful screening test for horses
suspected to suffer from inflammatory disease.
a) Glutarvac Test tube; Jorgen Kruuse A/S, Marslev,
Denmark.
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Sammendrag
Glutaraldehydprøvens evne til at skelne mellem akut
og kronisk inflammatorisk sygdom hos hest.
Glutaraldehydprøven (GP), en hurtig og billig test,
har været anvendt empirisk gennem mange år i
kvægpraksis for diagnosticering af inflammatoriske
sygdomme. GP bliver primært brugt til at påvise øget
serum koncentration af fibrinogen og globulin. Glu-
taraldehyd bindes til frie amino-grupper i fibrinogen
og globulin, som derpå danner et blodkoagel ved en
1. grads kemisk reaktion. Koaguleringstiden af GP
estimerer indholdet af de proteiner, som produceres i
et inflammatorisk respons. Anvendeligheden af GP
til diagnosticering af inflammatoriske tilstande i he-
stepraksis har aldrig været undersøgt før. Formålet
med dette studie er at bestemme GPs evne til at
skelne mellem akut og kronisk inflammatorisk syg-
dom hos hest. 37 heste, mistænkt for inflammatorisk
sygdom, blev evalueret på basis af GP, anamnese,
fuldstændig klinisk undersøgelse samt rutinemæssig
blodprøver. GP-tid, blodprøvesvar og klinisk udfald
blev sammenlignet statistisk. De heste, som var be-
stemt til at være akut afficeret på basis af anamnese,
klinisk undersøgelse og rutinemæssig blodprøve,
tenderede mod at have negativ GP (75%). Der kunne
ikke påvises sammenhæng mellem GP og fibrinogen
koncentration i blodet. Positiv GP forudsagde også et
fatalt udfald i 69% af de kliniske tilfælde. Resulta-
terne af dette studie indikerer, at GP kan være en
brugbar praktisk test til at skelne mellem akut og kro-
nisk inflammatorisk sygdom hos hest. 
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